This product has not been tested for freeze-thaw stability. However, in powder form, repeatedly removing this product from a freezer for the purpose of preparing fresh solutions, is not expected to be detrimental to the protein. Prepared solutions may be stored up to 1 week at 2 - 8 °C. It is not recommended to freeze stock solutions, as the freeze-thaw process may lead to protein degradation.
Please see the link below to review additional information available in the product datasheet:
https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/299/301/f4883pis.pdf
Przejdź do
Wybierz wielkość
| Rozmiar/SKU | Dostępność | Cena netto |
|---|---|---|
500 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 1840,00 zł |
1 g | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 3420,00 zł |
5 g | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 13 350,00 zł |
Informacje o tej pozycji
1840,00 zł
biological source
human plasma
Quality Segment
description
essentially plasmin(ogen) free
form
powder
quality
35-65% protein (≥90% of protein is clottable).
mol wt
α-chain 63.5 kDa, β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa
concentration
35-65% protein (biuret)
technique(s)
cell culture | mammalian: suitable
solubility
0.9% NaCl: soluble
storage temp.
−20°C
General description
Application
- fibrinogen adsorption assay performed on swCNTs (single-walled carbon nanotubes)
- the characterization of fibrinogen structure in the presence of CNT using CD (Circular dichroism) spectroscopy and temperature scan
- the preparation of RBC suspension obtained from venous blood of antecubital vein, to assess RBC aggregability
- fibrinolysis assay performed on mouse embryonic fibroblasts (MEFs)
- the preparation of fibrinogen-labeled gold (Fgn/Au)
- the quantification of in vitro angiogenesis by human microvascular endothelial cells and
- the assessment of fibrin-induced apoptosis and differentiation-regulation in trophoblast obtained from term human placentas.
Biochem/physiol Actions
Features and Benefits
Physical form
Analysis Note
Disclaimer
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description 35-65% protein (≥90% of protein is clottable). | description insoluble powder | description 50-70% protein (≥80% of protein is clottable) | description Type I-S, 65-85% protein (≥75% of protein is clottable) |
| biological source human plasma | biological source human plasma | biological source human plasma | biological source bovine plasma |
| technique(s) cell culture | mammalian: suitable | technique(s) indirect ELISA: suitable | technique(s) ELISA: suitable | technique(s) cell culture | mammalian: suitable |
| concentration 35-65% protein (biuret) | concentration - | concentration 50-70% protein (biuret) | concentration 65-85% (biuret) |
| mol wt γ chain 47 kDa (about 4% carbohydrate content), β-chain 56 kDa, α-chain 63.5 kDa, soluble dimer 340 kDa | mol wt - | mol wt soluble dimer 340 kDa, β-chain 56 kDa, α-chain 63.5 kDa, γ chain 47 kDa (about 4% carbohydrate content) | mol wt α-chain 63.5 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa, β-chain 56 kDa |
| form powder | form powder | form powder | form powder |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
Still not finding the right product?
Explore all of our products under Fibrinogen from human plasma
Klasa składowania
11 - Combustible Solids
Co się dzieje?
WGK 3
Temperatura zapłonu (°F)
Not applicable
Temperatura zapłonu (°C)
Not applicable
PPE (środki ochrony indywidualnej)
Eyeshields, Gloves, type N95 (US)
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
-
storage and thawing Is it possible to store at -20 freezer and repeated freezing and thawing
1 answer-
Helpful?
-
-
F4883-500MG contains Sodium Citrate and Sodium Chlorure. Is it possible to have their concentration ? What is the volume of sodium chloride we have to put in the bottle please?
1 answer-
This material is lyophilized from a solution of 75 mM NaCl (4.39 mg/mL), 10 mM Na Citrate (2.94 mg/mL). It can be solubilized in 0.85% (w/v) sodium chloride to 2 mg/ml, by layering the protein on top of the saline solution and placing it in a 37°C water bath for 4-6 hours, with gentle agitation.
Helpful?
-
-
Hello. For your F4883-500MG Fibrinogen product, is there 500mg of pure fibrinogen in the vial? Or is there 500 mg of reagent - of which a fraction is clottable Fibrinogen? Do you have preparation instructions for this reagent?
1 answer-
F4883-500MG contains 500 mg of solid. Fibrinogen can be solubilized in 0.85% (w/v) sodium chloride (2 mg/ml) by layering the protein on top of the saline solution and placing it in a 37 °C water bath for 4-6 hours with gentle agitation.
Helpful?
-



